ArticleClinical drug investigation2024

Comparative Cost-Effectiveness of Atezolizumab Versus Durvalumab as First-Line Combination Treatment with Chemotherapy for Patients with Extensive-Disease Small-Cell Lung Cancer in Japan.

Munenobu Kashiwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.